INOZYME PHARMA INC's ticker is INZY and the CUSIP is 45790W108. A total of 40 filers reported holding INOZYME PHARMA INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,242 | -6.8% | 295,608 | +23.6% | 0.00% | 0.0% |
| Q2 2023 | $1,332 | +25.0% | 239,200 | +28.5% | 0.00% | +100.0% |
| Q1 2023 | $1,066 | +291.9% | 186,100 | -28.1% | 0.00% | – |
| Q4 2022 | $272 | -99.9% | 258,900 | +66.6% | 0.00% | -100.0% |
| Q3 2022 | $416,000 | -26.2% | 155,400 | +31.4% | 0.00% | 0.0% |
| Q2 2022 | $564,000 | +1051.0% | 118,300 | +894.1% | 0.00% | – |
| Q1 2022 | $49,000 | – | 11,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CHI Advisors LLC | 1,009,117 | $26,529,000 | 9.44% |
| YALE UNIVERSITY | 113,502 | $2,984,000 | 9.13% |
| Sofinnova Investments, Inc. | 2,028,308 | $53,324,000 | 3.95% |
| Novo Holdings A/S | 2,569,379 | $67,549,000 | 3.35% |
| NEA Management Company, LLC | 2,444,379 | $64,263,000 | 2.72% |
| RA Capital Management | 2,003,653 | $52,676,000 | 0.96% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,150,299 | $30,241,000 | 0.74% |
| Rock Springs Capital Management LP | 879,954 | $23,134,000 | 0.59% |
| SPHERA FUNDS MANAGEMENT LTD. | 196,411 | $5,164,000 | 0.51% |
| Orbimed Advisors | 400,400 | $10,527,000 | 0.13% |